Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistance-Reference-Cited by-同舟云学术

Evaluation of T315I mutation frequency in chronic myeloid leukemia patients after imatinib resistance

Published:2013-05 Issue:3 Volume:18 Page:158-162
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Chahardouli Bahram¹,Zaker Farhad²,Mousavi Seied Asadollah³,Kazemi Ahmad¹,Ostadali Mohammadreza³,Nadali Fatemeh¹,Rostami Shahrbano³,Alimoghaddam Kamran³,Ghavamzade Ardeshir³

Affiliation:

1. Department of HematologySchool of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran

2. Department of HematologySchool of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran; and Cellular and Molecular Research Center, Tehran University of Medical Sciences, Tehran, Iran

3. HematologyOncology, and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1179/1607845412Y.0000000050

Reference31 articles.

1. Applying the discovery of the Philadelphia chromosome

2. Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

3. Imatinib Mesylate — A New Oral Targeted Therapy

4. Loss of Response to Imatinib: Mechanisms and Management

5. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of resistance to tyrosine kinase inhibitor‐targeted therapy and overcoming strategies;MedComm;2024-08-24

2. Utility of T315I mutation in Egyptian patients with chronic myeloid leukemia;Egyptian Journal of Basic and Applied Sciences;2024-02-26

3. Frequency of T315I Mutation in Patients with Chronic Myeloid Leukemia Before and During Imatinib Treatment: A Study in North-East of Iran;Journal of Advances in Medical and Biomedical Research;2023-06-01

4. Mechanistic Insights Into Co-Administration of Allosteric and Orthosteric Drugs to Overcome Drug-Resistance in T315I BCR-ABL1;Frontiers in Pharmacology;2022-03-18

5. Deep sequencing reveals the spectrum of BCR-ABL1 mutations upon front-line therapy resistance in chronic myeloid leukemia: An Eastern-Indian cohort study;Cancer Treatment and Research Communications;2022